Antiphospholipid syndrome (APS) is an autoimmune disorder that requires the persistence of autoantibodies: anti-β2-glycoprotein I (anti-β2GPI), anticardiolipin (aCL), and lupus anticoagulant (LA) tested positive at least 12 weeks apart [1]. Here, ACLY is linked to autoimmune polyendocrinopathy.